TrialNature communications2022

Randomized clinical trial to assess the protective efficacy of a Plasmodium vivax CS synthetic vaccine.

Myriam Arévalo-Herrera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.